{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:56:47Z","timestamp":1790683007354,"version":"4.1.0"},"reference-count":179,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1421,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Fresenius"},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.jacc.2009.08.012","type":"journal-article","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T08:54:29Z","timestamp":1256115269000},"page":"1660-1673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["Micronutrient Deficiencies"],"prefix":"10.1016","volume":"54","author":[{"given":"Victor","family":"Soukoulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil B.","family":"Dihu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evasio","family":"Pasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Strzelczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Taegtmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai","family":"Gheorghiade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2009.08.012_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0735-1097(01)01700-4","article-title":"Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study","volume":"39","author":"McCullough","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib2","first-page":"e25","article-title":"Heart disease and stroke statistics\u20142008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"117","author":"Rosamond","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.012_bib3","doi-asserted-by":"crossref","first-page":"III6","DOI":"10.1002\/clc.4960231503","article-title":"The economic burden of heart failure","volume":"23","author":"O'Connell","year":"2000","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib4","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology","volume":"29","author":"Dickstein","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2009.08.012_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2005.11.005","article-title":"HFSA 2006 comprehensive heart failure practice guideline","volume":"12","year":"2006","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2009.08.012_bib6","first-page":"23","article-title":"Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management","volume":"22","author":"Arnold","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","article-title":"2009 focused update incorporated into the ACC\/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"53","author":"Hunt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jacc.2008.03.061","article-title":"Heart failure-related hospitalization in the U.S., 1979 to 2004","volume":"52","author":"Fang","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cardfail.2007.12.001","article-title":"Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study","volume":"14","author":"Ahmed","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2009.08.012_bib10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jacc.2008.10.041","article-title":"Acute heart failure syndromes","volume":"53","author":"Gheorghiade","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jacc.2008.04.037","article-title":"Worsening heart failure hospitalization epidemic we do not know how to prevent and we do not know how to treat!","volume":"52","author":"Butler","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib12","series-title":"Alterations in Cardiac Metabolism in Heart Failure","author":"Taegtmeyer","year":"2004"},{"key":"10.1016\/j.jacc.2009.08.012_bib13","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/01.CIR.0000139340.88769.D5","article-title":"Cardiac metabolism as a target for the treatment of heart failure","volume":"110","author":"Taegtmeyer","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.012_bib14","series-title":"Robbins and Cotran Pathologic Basis of Disease","author":"Kumar","year":"2005"},{"key":"10.1016\/j.jacc.2009.08.012_bib15","first-page":"16","article-title":"ATP and the Heart","author":"Ingwall","year":"2002"},{"key":"10.1016\/j.jacc.2009.08.012_bib16","doi-asserted-by":"crossref","first-page":"3E","DOI":"10.1016\/j.amjcard.2008.02.064","article-title":"More than bricks and mortar: comments on protein and amino acid metabolism in the heart","volume":"101","author":"Taegtmeyer","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib17","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/01.RES.0000193563.53859.3e","article-title":"Cardiac remodeling: UPS lost in transit","volume":"97","author":"Razeghi","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2009.08.012_bib18","first-page":"IV1","article-title":"Carbohydrate interconversions and energy production","volume":"72","author":"Taegtmeyer","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.012_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0146-2806(94)90008-6","article-title":"Energy metabolism of the heart: from basic concepts to clinical applications","volume":"19","author":"Taegtmeyer","year":"1994","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/bj1860701","article-title":"Utilization of energy-providing substrates in the isolated working rat heart","volume":"186","author":"Taegtmeyer","year":"1980","journal-title":"Biochem J"},{"key":"10.1016\/j.jacc.2009.08.012_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10741-006-9194-4","article-title":"Micronutrients and their supplementation in chronic cardiac failure","volume":"11","author":"Witte","year":"2006","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2009.08.012_bib22","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jada.2009.05.011","article-title":"B-vitamin deficiency in hospitalized patients with heart failure","volume":"109","author":"Keith","year":"2009","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.jacc.2009.08.012_bib23","first-page":"417","article-title":"Conditioned nutritional requirements and the pathogenesis and treatment of myocardial failure","volume":"3","author":"Sole","year":"2000","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jacc.2009.08.012_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S0317167100023027","article-title":"Taurine decreases lesion severity in the hearts of cardiomyopathic hamsters","volume":"7","author":"Azari","year":"1980","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.jacc.2009.08.012_bib25","first-page":"21","article-title":"Reduction of doxorubicin-induced cardiotoxicity in mice by taurine","volume":"59","author":"Hamaguchi","year":"1988","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.jacc.2009.08.012_bib26","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.yjmcc.2008.03.001","article-title":"Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy","volume":"44","author":"Ito","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib27","first-page":"449","article-title":"Conditioned nutritional deficiencies in the cardiomyopathic hamster heart","volume":"17","author":"Keith","year":"2001","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib28","first-page":"351","article-title":"Primary carnitine deficiency","volume":"28","author":"Scholte","year":"1990","journal-title":"J Clin Chem Clin Biochem"},{"key":"10.1016\/j.jacc.2009.08.012_bib29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/HYPERTENSIONAHA.107.088609","article-title":"Pressure overload-induced cardiomyopathy in heterozygous carrier mice of carnitine transporter gene mutation","volume":"50","author":"Takahashi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2009.08.012_bib30","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/0002-8703(86)90360-1","article-title":"Beneficial effect of taurine in rabbits with chronic congestive heart failure","volume":"112","author":"Takihara","year":"1986","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2009.08.012_bib31","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1378\/chest.115.3.836","article-title":"Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation","volume":"115","author":"Anker","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2009.08.012_bib32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/07853890410017467","article-title":"Cardiac cachexia","volume":"36","author":"Anker","year":"2004","journal-title":"Ann Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib33","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2003.11.039","article-title":"Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure","volume":"43","author":"Kalantar-Zadeh","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib34","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2014an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10741-006-9195-3","article-title":"The management of conditioned nutritional requirements in heart failure","volume":"11","author":"Allard","year":"2006","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2009.08.012_bib36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00059-002-2360-0","article-title":"Conditioned nutritional requirements: therapeutic relevance to heart failure","volume":"27","author":"Sole","year":"2002","journal-title":"Herz"},{"key":"10.1016\/j.jacc.2009.08.012_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00005792-195102000-00002","article-title":"Myocardial metabolism in congestive heart failure","volume":"30","author":"Olson","year":"1951","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacc.2009.08.012_bib38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11906-006-0023-x","article-title":"On the hypothesis that the failing heart is energy starved: lessons learned from the metabolism of ATP and creatine","volume":"8","author":"Ingwall","year":"2006","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacc.2009.08.012_bib39","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1006\/jmcc.2000.1234","article-title":"Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction","volume":"32","author":"Remondino","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1196\/annals.1341.019","article-title":"Metabolic energetics and genetics in the heart","volume":"1047","author":"Taegtmeyer","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jacc.2009.08.012_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10741-007-9034-1","article-title":"Return to the fetal gene program protects the stressed heart: a strong hypothesis","volume":"12","author":"Rajabi","year":"2007","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2009.08.012_bib42","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/3253","article-title":"Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy","volume":"4","author":"Depre","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib43","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1053\/meta.2001.25605","article-title":"Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitro","volume":"50","author":"Doenst","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.jacc.2009.08.012_bib44","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/01.HYP.0000144292.69599.0c","article-title":"Mechanisms for increased glycolysis in the hypertrophied rat heart","volume":"44","author":"Nascimben","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2009.08.012_bib45","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/hc4901.100526","article-title":"Metabolic gene expression in fetal and failing human heart","volume":"104","author":"Razeghi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.012_bib46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejheart.2004.03.018","article-title":"Altered hetero- and homeometric autoregulation in the terminally failing human heart","volume":"7","author":"Brixius","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2009.08.012_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hfc.2004.11.002","article-title":"Neurohormonal upregulation in heart failure","volume":"1","author":"Tang","year":"2005","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.jacc.2009.08.012_bib48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11897-007-0022-5","article-title":"Role of reactive oxygen species in myocardial remodeling","volume":"4","author":"Zhang","year":"2007","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jacc.2009.08.012_bib49","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000139391","article-title":"Levels of taurine, amino acids and related compounds in plasma, vena cava, aorta and heart of rats after taurine administration","volume":"52","author":"Korang","year":"1996","journal-title":"Pharmacology"},{"issue":"Suppl","key":"10.1016\/j.jacc.2009.08.012_bib50","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/j.mito.2007.04.002","article-title":"Analysis of coenzyme Q in human blood and tissues","volume":"7","author":"Barshop","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jacc.2009.08.012_bib51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/039139880002300205","article-title":"Correlation between plasma carnitine, muscle carnitine and glycogen levels in maintenance hemodialysis patients","volume":"23","author":"Debska","year":"2000","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.jacc.2009.08.012_bib52","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/clinchem\/39.4.592","article-title":"Carnitine measurements in liver, muscle tissue, and blood in normal subjects","volume":"39","author":"Harper","year":"1993","journal-title":"Clin Chem"},{"issue":"Suppl","key":"10.1016\/j.jacc.2009.08.012_bib53","first-page":"S113","article-title":"Clinical laboratory monitoring of coenzyme Q10 use in neurologic and muscular diseases","volume":"121","author":"Steele","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"Suppl","key":"10.1016\/j.jacc.2009.08.012_bib54","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1016\/j.mito.2007.02.005","article-title":"Coenzyme Q10 in cardiovascular disease","volume":"7","author":"Pepe","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jacc.2009.08.012_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00005082-200207000-00003","article-title":"Coenzyme Q10 and cardiovascular disease: a review","volume":"16","author":"Sarter","year":"2002","journal-title":"J Cardiovasc Nurs"},{"key":"10.1016\/j.jacc.2009.08.012_bib56","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2004.10.009","article-title":"Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure","volume":"179","author":"Strey","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2009.08.012_bib57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/biof.5520180212","article-title":"The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10","volume":"18","author":"Langsjoen","year":"2003","journal-title":"Biofactors"},{"key":"10.1016\/j.jacc.2009.08.012_bib58","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/j.1552-4604.1993.tb03948.x","article-title":"Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study","volume":"33","author":"Ghirlanda","year":"1993","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2009.08.012_bib59","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Gissi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.08.012_bib60","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jacc.2005.08.060","article-title":"The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure","volume":"47","author":"Hanninen","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib61","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0002-9343(91)90007-K","article-title":"Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study","volume":"91","author":"Seligmann","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib62","first-page":"184","article-title":"Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy","volume":"10","author":"Zenuk","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2009.08.012_bib63","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/cvr\/14.9.537","article-title":"Furosemide-induced thiamine deficiency","volume":"14","author":"Yui","year":"1980","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2009.08.012_bib64","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MJT.0b013e3181728a1d","article-title":"Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients","volume":"15","author":"Harinstein","year":"2008","journal-title":"Am J Ther"},{"key":"10.1016\/j.jacc.2009.08.012_bib65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000067313","article-title":"Reverse remodeling of the failing human heart with mechanical unloading","volume":"98","author":"Razeghi","year":"2002","journal-title":"Cardiology"},{"issue":"Suppl","key":"10.1016\/j.jacc.2009.08.012_bib66","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1016\/0098-2997(94)90008-6","article-title":"Coenzyme Q10, plasma membrane oxidase and growth control","volume":"15","author":"Crane","year":"1994","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib67","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1073\/pnas.92.11.4887","article-title":"Coenzyme Q reductase from liver plasma membrane: purification and role in trans-plasma-membrane electron transport","volume":"92","author":"Villalba","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2009.08.012_bib68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12033-007-0052-y","article-title":"Bioenergetic and antioxidant properties of coenzyme Q10: recent developments","volume":"37","author":"Littarru","year":"2007","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.jacc.2009.08.012_bib69","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00395-003-0415-x","article-title":"Mitochondria and reperfusion injury","volume":"98","author":"Di Lisa","year":"2003","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib70","doi-asserted-by":"crossref","first-page":"28220","DOI":"10.1074\/jbc.M302297200","article-title":"Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property","volume":"278","author":"Papucci","year":"2003","journal-title":"J Biol Chem"},{"issue":"Suppl","key":"10.1016\/j.jacc.2009.08.012_bib71","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.1016\/S0098-2997(97)00003-4","article-title":"Coenzyme Q10 in the diet\u2014daily intake and relative bioavailability","volume":"18","author":"Weber","year":"1997","journal-title":"Mol Aspects Med"},{"issue":"Suppl","key":"10.1016\/j.jacc.2009.08.012_bib72","doi-asserted-by":"crossref","first-page":"s287","DOI":"10.1016\/0098-2997(94)90040-X","article-title":"Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure","volume":"15","author":"Baggio","year":"1994","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib73","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1536\/ihj.17.32","article-title":"A clinical study of the effect of coenzyme Q on congestive heart failure","volume":"17","author":"Ishiyama","year":"1976","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.jacc.2009.08.012_bib74","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0006-291X(05)80137-8","article-title":"Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant","volume":"182","author":"Folkers","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacc.2009.08.012_bib75","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.82.12.4240","article-title":"Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10","volume":"82","author":"Langsjoen","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2009.08.012_bib76","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1073\/pnas.82.3.901","article-title":"Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10","volume":"82","author":"Folkers","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2009.08.012_bib77","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1007\/BF00226855","article-title":"Statistical data support prediction of death within 6 months on low levels of coenzyme Q10 and other entities","volume":"71","author":"Jameson","year":"1993","journal-title":"Clin Investig"},{"key":"10.1016\/j.jacc.2009.08.012_bib78","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jacc.2008.07.044","article-title":"Coenzyme Q10: an independent predictor of mortality in chronic heart failure","volume":"52","author":"Molyneux","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib79","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1067\/mhj.2002.121927","article-title":"Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction","volume":"143","author":"Jeejeebhoy","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2009.08.012_bib80","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1093\/eurheartj\/ehl158","article-title":"Coenzyme Q10 and exercise training in chronic heart failure","volume":"27","author":"Belardinelli","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2009.08.012_bib81","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1007\/BF00226854","article-title":"Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study","volume":"71","author":"Morisco","year":"1993","journal-title":"Clin Investig"},{"issue":"Suppl","key":"10.1016\/j.jacc.2009.08.012_bib82","doi-asserted-by":"crossref","first-page":"s165","DOI":"10.1016\/0098-2997(94)90026-4","article-title":"Usefulness of coenzyme Q10 in clinical cardiology: a long-term study","volume":"15","author":"Langsjoen","year":"1994","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib83","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1007\/BF00226856","article-title":"Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment","volume":"71","author":"Langsjoen","year":"1993","journal-title":"Clin Investig"},{"issue":"Suppl","key":"10.1016\/j.jacc.2009.08.012_bib84","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1016\/S0098-2997(97)00006-X","article-title":"Treatment of hypertrophic cardiomyopathy with coenzyme Q10","volume":"18","author":"Langsjoen","year":"1997","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib85","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/biof.5520090225","article-title":"Coenzyme Q10 treatment in serious heart failure","volume":"9","author":"Munkholm","year":"1999","journal-title":"Biofactors"},{"key":"10.1016\/j.jacc.2009.08.012_bib86","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1443-9506.2003.00189.x","article-title":"Randomised double-blind, placebo-controlled trial of coenzyme Q, therapy in class II and III systolic heart failure","volume":"12","author":"Keogh","year":"2003","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jacc.2009.08.012_bib87","doi-asserted-by":"crossref","first-page":"636","DOI":"10.7326\/0003-4819-132-8-200004180-00006","article-title":"The effect of coenzyme Q10 in patients with congestive heart failure","volume":"132","author":"Khatta","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib88","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0735-1097(99)00064-9","article-title":"Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure","volume":"33","author":"Watson","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib89","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7326\/0003-4819-133-9-200011070-00020","article-title":"Coenzyme Q10 and congestive heart failure","volume":"133","author":"Sinatra","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib90","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cardfail.2006.03.007","article-title":"The impact of coenzyme Q10 on systolic function in patients with chronic heart failure","volume":"12","author":"Sander","year":"2006","journal-title":"J Card Fail"},{"issue":"Suppl","key":"10.1016\/j.jacc.2009.08.012_bib91","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1016\/S0098-2997(97)00042-3","article-title":"Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials","volume":"18","author":"Soja","year":"1997","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib92","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/biof.5520180210","article-title":"Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure","volume":"18","author":"Mortensen","year":"2003","journal-title":"Biofactors"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2009.08.012_bib93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00128238","article-title":"Propionyl-L-carnitine: biochemical significance and possible role in cardiac metabolism","volume":"5","author":"Siliprandi","year":"1991","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2009.08.012_bib94","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0033-0620(97)80037-0","article-title":"Carnitine and its derivatives in cardiovascular disease","volume":"40","author":"Arsenian","year":"1997","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2009.08.012_bib95","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/01.RES.77.4.726","article-title":"Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation","volume":"77","author":"Schonekess","year":"1995","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2009.08.012_bib96","first-page":"H441","article-title":"Propionyl-L-carnitine-mediated improvement in contractile function of rat hearts oxidizing acetoacetate","volume":"268","author":"Russell","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib97","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00005082-200601000-00004","article-title":"Supplemental conditionally essential nutrients in cardiovascular disease therapy","volume":"21","author":"Kendler","year":"2006","journal-title":"J Cardiovasc Nurs"},{"key":"10.1016\/j.jacc.2009.08.012_bib98","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1253\/jcj.54.12_1471","article-title":"Myocardial free carnitine and fatty acylcarnitine levels in patients with chronic heart failure","volume":"54","author":"Masumura","year":"1990","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jacc.2009.08.012_bib99","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0002-9149(90)91383-H","article-title":"Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases","volume":"65","author":"Regitz","year":"1990","journal-title":"Am J Cardiol"},{"issue":"Suppl 5","key":"10.1016\/j.jacc.2009.08.012_bib100","first-page":"34","article-title":"Transport and function of L-carnitine and L-propionylcarnitine: relevance to some cardiomyopathies and cardiac ischemia","volume":"76","author":"Siliprandi","year":"1987","journal-title":"Z Kardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib101","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/euhj.1998.1271","article-title":"Study on propionyl-L-carnitine in chronic heart failure","volume":"20","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2009.08.012_bib102","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/A:1007721917561","article-title":"Acute and chronic effects of propionyl-L-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure","volume":"12","author":"Anand","year":"1998","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2009.08.012_bib103","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1023\/A:1007883822625","article-title":"Prolonged oral L-carnitine substitution increases bicycle ergometer performance in patients with severe, ischemically induced cardiac insufficiency","volume":"13","author":"Loster","year":"1999","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2009.08.012_bib104","first-page":"1101","article-title":"Controlled study on the therapeutic efficacy of propionyl-L-carnitine in patients with congestive heart failure","volume":"42","author":"Mancini","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jacc.2009.08.012_bib105","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1067\/mhj.2000.103917","article-title":"Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration","volume":"139","author":"Rizos","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2009.08.012_bib106","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0735-1097(95)80010-E","article-title":"Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) trial","volume":"26","author":"Iliceto","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib107","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1749-6632.1982.tb31195.x","article-title":"Thiamin pyrophosphokinase: structure, properties, and role in thiamin metabolism","volume":"378","author":"Voskoboyev","year":"1982","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jacc.2009.08.012_bib108","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/1097-4547(20001015)62:2<286::AID-JNR13>3.0.CO;2-0","article-title":"Thiamine deficiency results in metabolic acidosis and energy failure in cerebellar granule cells: an in vitro model for the study of cell death mechanisms in Wernicke's encephalopathy","volume":"62","author":"Pannunzio","year":"2000","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jacc.2009.08.012_bib109","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1527-5299.2007.06260.x","article-title":"Loop diuretic therapy, thiamine balance, and heart failure","volume":"13","author":"Sica","year":"2007","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.jacc.2009.08.012_bib110","series-title":"Modern Nutrition in Health and Disease","first-page":"1368","article-title":"Nutritional disorders of the nervous system","author":"Roman","year":"2006"},{"key":"10.1016\/j.jacc.2009.08.012_bib111","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1536\/ihj.2.42","article-title":"Experimental studies on the beriberi heart","volume":"2","author":"Yoshitoshi","year":"1961","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.jacc.2009.08.012_bib112","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1566524013363870","article-title":"Molecular mechanisms of thiamine utilization","volume":"1","author":"Singleton","year":"2001","journal-title":"Curr Mol Med"},{"issue":"Suppl","key":"10.1016\/j.jacc.2009.08.012_bib113","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3177\/jnsv.22.Supplement_25","article-title":"Catecholamine metabolism in thiamine-deficient rats","volume":"22","author":"Iwata","year":"1976","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"10.1016\/j.jacc.2009.08.012_bib114","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1476-5381.1963.tb01309.x","article-title":"Pharmacological responses of thiamine-deficient rat tissues","volume":"20","author":"Boullin","year":"1963","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1016\/j.jacc.2009.08.012_bib115","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1536\/ihj.12.474","article-title":"Relationship between thiamine deficient cardiac lesions and myocardial and blood pyruvic acid contents","volume":"12","author":"Yamashita","year":"1971","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.jacc.2009.08.012_bib116","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/01.RES.16.3.238","article-title":"Effect of thiamine deficiency on potential myocardial contractility","volume":"16","author":"Aldinger","year":"1965","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2009.08.012_bib117","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1253\/jcj.43.99","article-title":"Cardiovascular effects of exercise in hamsters with experimental thiamine deficiency","volume":"43","author":"Hirota","year":"1979","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jacc.2009.08.012_bib118","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1152\/ajplegacy.1976.231.5.1390","article-title":"Mechanical properties of rat cardiac muscle during experimental thiamine deficiency","volume":"231","author":"Cohen","year":"1976","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib119","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/0022-2828(90)90073-B","article-title":"Altered contractile properties of rat cardiac muscle during experimental thiamine deficiency and food deprivation","volume":"22","author":"Cappelli","year":"1990","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/path.1711020204","article-title":"The ultrastructure of the myocardium in the thiamine-deficient rat","volume":"102","author":"Davies","year":"1970","journal-title":"J Pathol"},{"key":"10.1016\/j.jacc.2009.08.012_bib121","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0006-2952(97)00178-0","article-title":"Thiamine deficiency in cardiac cells in culture","volume":"54","author":"Zangen","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jacc.2009.08.012_bib122","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-8223(95)00148-4","article-title":"Thiamin status, diuretic medications, and the management of congestive heart failure","volume":"95","author":"Brady","year":"1995","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.jacc.2009.08.012_bib123","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/ageing\/21.1.67","article-title":"Thiamine status of elderly patients with cardiac failure","volume":"21","author":"Kwok","year":"1992","journal-title":"Age Ageing"},{"key":"10.1016\/j.jacc.2009.08.012_bib124","first-page":"113","article-title":"Thiamine status of elderly patients with cardiac failure including the effects of supplementation","volume":"64","author":"Pfitzenmeyer","year":"1994","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.jacc.2009.08.012_bib125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2796.1997.tb00022.x","article-title":"No difference in blood thiamine diphosphate levels between Swedish Caucasian patients with congestive heart failure treated with furosemide and patients without heart failure","volume":"242","author":"Yue","year":"1997","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib126","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0002-9343(99)80349-0","article-title":"Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy","volume":"98","author":"Shimon","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib127","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ajem.2006.05.008","article-title":"Thiamine for the treatment of acute decompensated heart failure","volume":"25","author":"Smithline","year":"2007","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib128","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.ahj.2003.11.007","article-title":"Are hematinic deficiencies the cause of anemia in chronic heart failure?","volume":"147","author":"Witte","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2009.08.012_bib129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1253\/jcj.56.95","article-title":"Usefulness of taurine in chronic congestive heart failure and its prospective application","volume":"56","author":"Azuma","year":"1992","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jacc.2009.08.012_bib130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0306-3623(97)00309-1","article-title":"Review of some actions of taurine on ion channels of cardiac muscle cells and others","volume":"30","author":"Satoh","year":"1998","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.jacc.2009.08.012_bib131","first-page":"H238","article-title":"Effect of taurine on calcium paradox and ischemic heart failure","volume":"240","author":"Kramer","year":"1981","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib132","first-page":"2691","article-title":"Regulation of calcium homeostasis in the heart by taurine","volume":"39","author":"Schaffer","year":"1980","journal-title":"Fed Proc"},{"key":"10.1016\/j.jacc.2009.08.012_bib133","series-title":"Taurine in Health and Disease","article-title":"Reactivity of taurine with aldehydes and its physiologic role","author":"Ogarsawa","year":"1994"},{"key":"10.1016\/j.jacc.2009.08.012_bib134","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/jn\/122.11.2066","article-title":"Cysteine and glycine supplementation modulate the metabolic response to tumor necrosis factor alpha in rats fed a low protein diet","volume":"122","author":"Grimble","year":"1992","journal-title":"J Nutr"},{"key":"10.1016\/j.jacc.2009.08.012_bib135","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00005344-200305000-00012","article-title":"Possible cause of taurine-deficient cardiomyopathy: potentiation of angiotensin II action","volume":"41","author":"Schaffer","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2009.08.012_bib136","first-page":"2685","article-title":"Physiological and experimental regulation of taurine content in the heart","volume":"39","author":"Huxtable","year":"1980","journal-title":"Fed Proc"},{"key":"10.1016\/j.jacc.2009.08.012_bib137","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0378-1097(03)00611-6","article-title":"Taurine: new implications for an old amino acid","volume":"226","author":"Schuller-Levis","year":"2003","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.jacc.2009.08.012_bib138","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-4899-1471-2_6","article-title":"Expression and regulation of the taurine transporter in cultured cell lines of human origin","volume":"359","author":"Ganapathy","year":"1994","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jacc.2009.08.012_bib139","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0024-3205(77)90261-2","article-title":"Loss of cardiac muscle taurine after acute left ventricular ischemia","volume":"21","author":"Crass","year":"1977","journal-title":"Life Sci"},{"key":"10.1016\/j.jacc.2009.08.012_bib140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-1-4899-0405-8_16","article-title":"Potentiation of myocardial ischemic injury by drug-induced taurine depletion","volume":"217","author":"Schaffer","year":"1987","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jacc.2009.08.012_bib141","doi-asserted-by":"crossref","first-page":"26E","DOI":"10.1016\/j.amjcard.2008.02.078","article-title":"Morphometric changes induced by amino acid supplementation in skeletal and cardiac muscles of old mice","volume":"101","author":"Corsetti","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib142","doi-asserted-by":"crossref","first-page":"30A","DOI":"10.1016\/j.amjcard.2003.11.007","article-title":"Effect of amino acid mixture on the isolated ischemic heart","volume":"93","author":"Pasini","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib143","doi-asserted-by":"crossref","first-page":"78E","DOI":"10.1016\/j.amjcard.2008.03.005","article-title":"Impairment in walking capacity and myocardial function in the elderly: is there a role for nonpharmacologic therapy with nutritional amino acid supplements?","volume":"101","author":"Scognamiglio","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib144","doi-asserted-by":"crossref","first-page":"104E","DOI":"10.1016\/j.amjcard.2008.03.008","article-title":"Oral amino acid supplements improve exercise capacities in elderly patients with chronic heart failure","volume":"101","author":"Aquilani","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib145","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ejheart.2008.09.002","article-title":"Adequate energy-protein intake is not enough to improve nutritional and metabolic status in muscle-depleted patients with chronic heart failure","volume":"10","author":"Aquilani","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2009.08.012_bib146","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.nutr.27.061406.093621","article-title":"Creatine: endogenous metabolite, dietary, and therapeutic supplement","volume":"27","author":"Brosnan","year":"2007","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.jacc.2009.08.012_bib147","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0735-1097(02)02160-5","article-title":"Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy","volume":"40","author":"Beer","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib148","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1161\/01.CIR.96.7.2190","article-title":"Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy","volume":"96","author":"Neubauer","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.012_bib149","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.yjmcc.2005.05.003","article-title":"The fall in creatine levels and creatine kinase isozyme changes in the failing heart are reversible: complex post-transcriptional regulation of the components of the CK system","volume":"39","author":"Shen","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib150","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/CIRCULATIONAHA.106.613646","article-title":"Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium","volume":"114","author":"Smith","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.012_bib151","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/clc.4960190905","article-title":"Hemodynamic effects of creatine phosphate in patients with congestive heart failure: a double-blind comparison trial versus placebo","volume":"19","author":"Ferraro","year":"1996","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib152","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0008-6363(95)00062-3","article-title":"Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance","volume":"30","author":"Gordon","year":"1995","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2009.08.012_bib153","first-page":"218","article-title":"Creatine supplementation improves muscle strength in patients with congestive heart failure","volume":"61","author":"Kuethe","year":"2006","journal-title":"Pharmazie"},{"key":"10.1016\/j.jacc.2009.08.012_bib154","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/hrt.2007.126359","article-title":"Vitamin D and calcium dyshomoeostasis-associated heart failure","volume":"94","author":"Weber","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2009.08.012_bib155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0735-1097(02)02624-4","article-title":"Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?","volume":"41","author":"Zittermann","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib156","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/hrt.2007.119792","article-title":"Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure","volume":"94","author":"Maiya","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2009.08.012_bib157","first-page":"E675","article-title":"Involvement of vitamin D3 with cardiovascular function","volume":"253","author":"Weishaar","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib158","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/cvr\/cvn261","article-title":"Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium","volume":"81","author":"Weber","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2009.08.012_bib159","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/0735-1097(93)90095-I","article-title":"Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study","volume":"21","author":"Eichhorn","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib160","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0735-1097(10)80329-8","article-title":"Prognostic importance of the serum magnesium concentration in patients with congestive heart failure","volume":"16","author":"Gottlieb","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib161","first-page":"123","article-title":"Potassium and magnesium depletions in congestive heart failure\u2014pathophysiology, consequences and replenishment","volume":"15","author":"Iezhitsa","year":"2005","journal-title":"Clin Calcium"},{"key":"10.1016\/j.jacc.2009.08.012_bib162","first-page":"397","article-title":"Are failured cardiomyopathies a zinc-deficit related disease?","volume":"89","author":"Ripa","year":"1998","journal-title":"Minerva Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib163","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10741-006-9188-2","article-title":"Selenium and antioxidant defenses as major mediators in the development of chronic heart failure","volume":"11","author":"de Lorgeril","year":"2006","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2009.08.012_bib164","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.hlc.2006.07.013","article-title":"Nutritional deficiency of selenium secondary to weight loss (bariatric) surgery associated with life-threatening cardiomyopathy","volume":"16","author":"Boldery","year":"2007","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jacc.2009.08.012_bib165","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.numecd.2007.10.003","article-title":"Triple nutrient supplementation improves survival, infarct size and cardiac function following myocardial infarction in rats","volume":"18","author":"Briet","year":"2008","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2009.08.012_bib166","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1093\/eurheartj\/ehi442","article-title":"The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure","volume":"26","author":"Witte","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2009.08.012_bib167","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.08.012_bib168","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.08.012_bib169","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.298.17.2009","article-title":"Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials","volume":"298","author":"McMurray","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.08.012_bib170","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(08)61239-8","article-title":"Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.08.012_bib171","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/01.CIR.0000095029.57483.60","article-title":"Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy","volume":"108","author":"Bello","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.012_bib172","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(03)13801-9","article-title":"Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial","volume":"362","author":"Cleland","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.08.012_bib173","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.amjcard.2003.12.023","article-title":"Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"93","author":"Seghatol","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib174","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10741-005-7540-6","article-title":"Non-invasive cardiac evaluation in heart failure patients using magnetic resonance imaging: a feasibility study","volume":"10","author":"Shors","year":"2005","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2009.08.012_bib175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev.med.50.1.75","article-title":"Concept and evaluation of hibernating myocardium","volume":"50","author":"Rahimtoola","year":"1999","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib176","doi-asserted-by":"crossref","first-page":"44A","DOI":"10.1016\/j.amjcard.2003.11.010","article-title":"Effects of amino acid supplementation on left ventricular remodeling in patients with chronic heart failure with decreased systolic function and diabetes mellitus: rationale and design of a magnetic resonance imaging study","volume":"93","author":"Klein","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.08.012_bib177","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.012_bib178","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.08.012_bib179","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709027971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709027971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:35:21Z","timestamp":1760013321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109709027971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":179,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0735109709027971"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2009.08.012","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Micronutrient Deficiencies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2009.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}